Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
08/01/1996 | CA2168139A1 Anti-parasitic activity |
08/01/1996 | CA2168067A1 Method for treating smoking-related bone loss |
07/31/1996 | EP0724004A1 Antioxidant-containing blowing agent |
07/31/1996 | EP0723969A1 Phosphonocarboxylic acid derivatives and their use in treating degenerative articular ailments |
07/31/1996 | EP0723963A1 4-amino-benzoylguanidine derivatives |
07/31/1996 | EP0723962A1 Arylalkyl-thiadiazinones |
07/31/1996 | EP0723959A1 Heterocyclic compounds as tachykinin receptor antagonists, process for their preparation and pharmaceuticals containing them |
07/31/1996 | EP0723958A1 Synthesis of substantially pure terfenadine derivatives |
07/31/1996 | EP0723956A1 Basically substituted benzoylguanidines, process for their preparation, their use as medicaments or diagnostics as well as medicaments containing them |
07/31/1996 | EP0723781A2 Transdermal formulation of xanomeline |
07/31/1996 | EP0723780A2 2-Phenyl-3-azoylbenzothiopenes for decreasing serum calcium levels |
07/31/1996 | EP0723779A1 Medicament for treatment of hypothalamic amenorrhea |
07/31/1996 | EP0723778A1 Composition for modulation of apoptosis comprising a factor influencing the intracellular level of methional or malondialdehyde |
07/31/1996 | EP0723774A1 Cosmetic, dermatological or pharmaceutical composition comprising an antagonist of CGRP |
07/31/1996 | EP0723664A1 Detection and treatment of breast and gynecological cancer |
07/31/1996 | EP0723584A1 Recombinant infectious laryngotracheitis virus and uses thereof |
07/31/1996 | EP0723579A1 Protease-containing cleaning compositions |
07/31/1996 | EP0723547A1 Boronated metalloporphyrins and therapeutic methods |
07/31/1996 | EP0723546A1 1,2,4 - Triazolo (1,5-a) pyrimitives and their use for treatment of neurological disorders |
07/31/1996 | EP0723545A1 Quinolizinone type compounds |
07/31/1996 | EP0723544A1 ALKOXY ALKYL CARBAMATES FROM IMIDAZO (1,2-a)PYRIDINES |
07/31/1996 | EP0723541A1 Indole derivatives as nmda antagonists |
07/31/1996 | EP0723540A1 Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
07/31/1996 | EP0723539A1 Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
07/31/1996 | EP0723538A1 Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
07/31/1996 | EP0723537A1 Benzothiophenes and related compounds as estrogen agonists |
07/31/1996 | EP0723533A1 1n-alkyl-n-arylpyrimidinamines and derivatives thereof |
07/31/1996 | EP0723460A1 Gene therapy of the nervous system |
07/31/1996 | EP0723451A1 Use of lithium compounds for treating high blood pressure |
07/31/1996 | EP0723450A1 Inhibition of urinary calculi growth |
07/31/1996 | EP0723449A1 Endothelin receptor antagonists |
07/31/1996 | EP0723448A1 Use of peniclorin for the treatment of posttherapeutic neuralgia |
07/31/1996 | EP0723447A1 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
07/31/1996 | EP0723446A1 Treatment of allergic disorders with terfenadine carboxylate |
07/31/1996 | EP0723445A1 Analgesic agent and its use |
07/31/1996 | EP0723444A1 Levobupivacaine useful for managing chronic pain |
07/31/1996 | EP0723443A1 Use of alpha receptor antagonists for the treatment of chronic muscle pain |
07/31/1996 | EP0723442A1 Lactone compounds for treating patients with precancerous lesions |
07/31/1996 | EP0723441A1 Aminimide-containing molecules and materials as molecular recognition agents |
07/31/1996 | EP0723440A1 Therapeutic delivery compositions and methods of use thereof |
07/31/1996 | EP0723439A1 Combination of progesterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for peri- and post-menopausal women |
07/31/1996 | EP0723438A1 Substituted urea and isothiourea derivatives as no synthase inhibitors |
07/31/1996 | EP0723437A1 Multiple unit pharmaceutical preparation containing proton pump inhibitor |
07/31/1996 | EP0723436A1 Multiple unit tableted dosage form i |
07/31/1996 | EP0723435A1 Once-a-day metoprolol oral dosage form |
07/31/1996 | EP0723434A1 New beads for controlled release and a pharmaceutical preparation containing the same |
07/31/1996 | EP0723399A1 Method for inhibiting nucleoside and nucleobase transport and virus replication in mammalian cells |
07/31/1996 | EP0723398A1 Superoxide dismutase and mimetics thereof |
07/31/1996 | EP0660826A4 5,5-disubstituted hydantoins. |
07/31/1996 | EP0648223A4 Substituted lactose derivatives as cell adhesion inhibitors. |
07/31/1996 | EP0647219B1 Derivatives in the vitamin d series modified at the 20 position, a method of preparing such derivatives, intermediates used in this method, pharmaceutical preparations containing the derivatives and their use in the preparation of drugs |
07/31/1996 | EP0473612B1 Fertility enhancement |
07/31/1996 | EP0472661B1 Therapeutic application of an anti-invasion compound |
07/31/1996 | CN1128044A Fungicidal methods and compositions for killing yeast and sporular microorganisms |
07/31/1996 | CN1128031A 15,15-dialkyl-substituted derivatives of estradiol |
07/31/1996 | CN1128030A Heterocyclic amines having central nervous system activity |
07/31/1996 | CN1128029A Thiazole derivatives as lipoxygenase inhibitors |
07/31/1996 | CN1128028A N-morpholino-N-nitrosaminoacetonitril cyclodextrin inclusion complexes |
07/31/1996 | CN1128025A Benzoxazinones and benzothiazinones endowed with therapeutic activity |
07/31/1996 | CN1128022A Nipecotic acid derivatives as antithrombic compounds |
07/31/1996 | CN1127991A Method to inhibit restenosis |
07/31/1996 | CN1127990A Encapsulated medicine |
07/31/1996 | CN1127989A Improved nicotine lozenge and therapeutic method for smoking cessation |
07/31/1996 | CN1127757A New tetrahydropyran compounds, process for the preparation thereof, and pharmaceutical compositions containing them |
07/31/1996 | CN1127753A New imidazolidines substituted by a heterocycle, their preparation process and intermediates, their use as medicaments NAD the pharmaceutical compositions containing them |
07/31/1996 | CN1127752A Method of manufacturing the cycloheptimidazole derivatives |
07/31/1996 | CN1127749A Amino acid-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them |
07/31/1996 | CN1127636A Oral pill for treatment of toothache |
07/31/1996 | CN1127635A Pharmaceutical composition |
07/31/1996 | CA2168315A1 Basically-substituted benzoylguanidines, a process for preparing them, their use as a medicament or diagnostic agent, and a medicament containing them |
07/31/1996 | CA2167999A1 Venlafaxine in the treatment of hypothalamic amenorrhea in non-depressed women |
07/30/1996 | US5541343 Cyclic imino derivatives and pharmaceutical compositions containing them |
07/30/1996 | US5541340 Method of preparing 1,2,3,3a,8,8a-hexahydro-3a,8(and 1,3a,8)-Di(and Tri)methylpyrrolo[2,3,-b] indoles |
07/30/1996 | US5541339 CC-1065 analogs having two CPI subunits |
07/30/1996 | US5541325 Enzyme inhibitors, antiallergens |
07/30/1996 | US5541324 Anxiolytic agents, sedatives or hypnotic agents |
07/30/1996 | US5541319 Reacting substituted benzazepine ether with boron trihalide to form hydroxy group, forming salt with base if desired |
07/30/1996 | US5541297 Hypoimmunogenic immunoconjugate of antibody fragment which binds to antigen associated with tumor or protozoa conjugated to drug or modified toxin and to polysaccharide or polyether through thiol-binding linker |
07/30/1996 | US5541232 Treatment of multidrug resistant diseases |
07/30/1996 | US5541231 Improving storage stability of the antidepressant, bupropion hydrochloride |
07/30/1996 | US5541229 Benzimidazoles and medicaments containing these compounds |
07/30/1996 | US5541228 Melatonergic agents |
07/30/1996 | US5541227 Ibuprofen-containing medicament |
07/30/1996 | US5541226 Topical compositions for re-epithelialization of persistent epithelial defects |
07/30/1996 | US5541225 α-Linolenic acid and eicosatetraynoic acid in the prevention and treatment of ventricular tachyarrhythmia |
07/30/1996 | US5541224 Carbanilide anticoccidials |
07/30/1996 | US5541221 Pharmaceutical compositions and method for administering 3 and 4-substituted 2(5H)-furanones to a mammal for inhibiting bone loss |
07/30/1996 | US5541220 Skin disorders, wound healing agents, antiinflammatory agents and radiation resistance |
07/30/1996 | US5541219 Antiinflammatory agents; aids |
07/30/1996 | US5541216 Memory enhancing and analgsic 1,2,3,3A,8,8A-Hexahydro--3A, 8(And1,3A,8)-Di (and Tri) Methylpyrrolo(2,3-B Indoles |
07/30/1996 | US5541215 Antiretroviral compounds; treating hiv infections |
07/30/1996 | US5541212 Use of cimetidine for the control of retrovirus infections |
07/30/1996 | US5541211 Administration of atipamezole to elicit a yohimbine-like alpha-adrenoreceptor antagonistic noradrenergic transmission |
07/30/1996 | US5541210 5-(2-imidazolinylamino)benzimidazole compounds useful as alpha-2 andrenoceptor agonists |
07/30/1996 | US5541209 Method of treating or preventing cardiac arrhythmia employing an N-substituted heterocyclic derivative |
07/30/1996 | US5541208 Potassium channel antagonist, alzheimer*s disease and cognition activators |
07/30/1996 | US5541207 Anti-neoplastic anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment |
07/30/1996 | US5541206 Retroviral protease inhibiting compounds |
07/30/1996 | US5541205 Antiinflammatory agents; antiasthma agents |
07/30/1996 | US5541204 Aryloxypropanolamine β 3 adrenergic agonists |